The Role of the Non-Steroidal Mineralocorticoid Antagonist Finerenone in Cardiorenal Management

被引:0
|
作者
Craig J. Beavers
机构
[1] University of Kentucky College of Pharmacy,Department of Practice and Science
来源
Current Cardiology Reports | 2022年 / 24卷
关键词
Finerenone; Chronic kidney disease; Cardiovascular disease; Heart failure; Type 2 diabetes mellitus; Mineralocorticoid antagonist;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1785 / 1790
页数:5
相关论文
共 50 条
  • [1] The Role of the Non-Steroidal Mineralocorticoid Antagonist Finerenone in Cardiorenal Management
    Beavers, Craig J.
    CURRENT CARDIOLOGY REPORTS, 2022, 24 (12) : 1785 - 1790
  • [2] The non-steroidal mineralocorticoid receptor antagonist finerenone prevents structural cardiac remodeling
    Lavall, D.
    Jacobs, N.
    Mahfoud, F.
    Kolkhof, P.
    Boehm, M.
    Laufs, U.
    EUROPEAN HEART JOURNAL, 2019, 40 : 3326 - 3326
  • [3] The non-steroidal mineralocorticoid receptor antagonist finerenone prevents cardiac fibrotic remodeling
    Lavall, Daniel
    Jacobs, Nadine
    Mahfoud, Felix
    Kolkhof, Peter
    Boehm, Michael
    Laufs, Ulrich
    BIOCHEMICAL PHARMACOLOGY, 2019, 168 : 173 - 183
  • [4] The non-steroidal mineralocorticoid receptor antagonist finerenone and heart failure with preserved ejection fraction
    Ulrich Kintscher
    Frank Edelmann
    Cardiovascular Diabetology, 22
  • [5] The non-steroidal mineralocorticoid receptor antagonist finerenone and heart failure with preserved ejection fraction
    Kintscher, Ulrich
    Edelmann, Frank
    CARDIOVASCULAR DIABETOLOGY, 2023, 22 (01)
  • [6] Steroidal and non-steroidal mineralocorticoid receptor antagonists in cardiorenal medicine
    Agarwal, Rajiv
    Kolkhof, Peter
    Bakris, George
    Bauersachs, Johann
    Haller, Hermann
    Wada, Takashi
    Zannad, Faiez
    EUROPEAN HEART JOURNAL, 2021, 42 (02) : 152 - 161
  • [7] A comprehensive review of finerenone-a third-generation non-steroidal mineralocorticoid receptor antagonist
    Zhai, Shuhui
    Ma, Baisheng
    Chen, Weiwei
    Zhao, Qini
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2024, 11
  • [8] Non-steroidal mineralocorticoid receptor antagonists in cardiorenal disease
    Pandey, Arjun K.
    Bhatt, Deepak L.
    Cosentino, Francesco
    Marx, Nikolaus
    Rotstein, Ori
    Pitt, Bertram
    Pandey, Ambirash
    Butler, Javed
    Verma, Subodh
    EUROPEAN HEART JOURNAL, 2022, 43 (31) : 2931 - 2945
  • [9] Effects of Non-Steroidal Mineralocorticoid Antagonist (Finerenone) in Western Diet-Induced Kidney Disease
    Myakala, Komuraiah
    Ribeiro, Patricia de Carvalho
    Wang, Xiaoxin
    Korolowicz, Kyle E.
    Rodriguez, Olga C.
    Albanese, Chris
    Levi, Moshe
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 668 - 668
  • [10] Finerenone - are we there yet with a non-steroidal mineralocorticoid receptor antagonist for the treatment of diabetic chronic kidney disease?
    Doggrell, Sheila A.
    EXPERT OPINION ON PHARMACOTHERAPY, 2021, 22 (10) : 1253 - 1256